Stay updated with breaking news from Adicet Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the pricing of an...
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that it has commenced...
StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report released on Tuesday. Separately, Wedbush reissued an outperform rating and issued a $5.00 target price on shares of Adicet Bio in a report on Thursday, January 4th. One equities research analyst has rated the stock with a […]
StockNews.com upgraded shares of Adicet Bio (NASDAQ:ACET – Free Report) to a sell rating in a research report released on Tuesday. Separately, Wedbush reissued an outperform rating and issued a $5.00 target price on shares of Adicet Bio in a report on Thursday, January 4th. One equities research analyst has rated the stock with a […]
Adicet Bio, Inc. (NASDAQ:ACET – Free Report) – Stock analysts at Wedbush issued their FY2028 earnings per share (EPS) estimates for Adicet Bio in a research note issued to investors on Thursday, January 4th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($1.16) for the year. Wedbush has a […]